Skip to content

STRIDE

BEHAVIORAL6 trials

Sponsors

University of New Mexico, VA Office of Research and Development, Massachusetts General Hospital, Joslin Diabetes Center, AstraZeneca

Conditions

Adherence, MedicationBreast CancerDementiaDiabetesEarly AmbulationHepatocellular CarcinomaHormone Receptor Positive Breast CancerHypoglycemia; Drug

Unknown Phase

Mediators and Moderators of Exercise Behavior Change
CompletedNCT01091857
University of New MexicoIncrease Positive Attitudes, Perceived Normative Support, Self-efficacy, and Intentions, Increase Self-reported Physical Activity, Validate STRIDE Exercise Intervention in Sedentary Individuals
Start: 2004-09-30End: 2009-08-31Updated: 2023-07-11
Optimizing Function and Independence Through STRIDE
CompletedNCT03300336
VA Office of Research and DevelopmentEarly Ambulation
Start: 2017-10-05End: 2021-10-30Updated: 2023-09-28
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
CompletedNCT03837496
Massachusetts General HospitalAdherence, Medication, Breast Cancer
Start: 2019-10-28End: 2021-12-01Updated: 2022-11-18
Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's
CompletedNCT05535478
Joslin Diabetes CenterDementia, Diabetes, Hypoglycemia; Drug
Start: 2023-01-31End: 2025-07-14Updated: 2025-07-30
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
RecruitingNCT07607769
AstraZenecaHepatocellular Carcinoma
Start: 2026-04-16End: 2028-10-31Target: 200Updated: 2026-08-27
Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy
Not yet recruitingNCT07759947
Massachusetts General HospitalHormone Receptor Positive Breast Cancer
Start: 2027-02-01End: 2031-06-01Target: 400Updated: 2026-08-12

Related Papers